Arca
Skip to content
Tools
Tools

Uric acid

Small molecule in Homo sapiens that 3 drugs act on.

  • Drugs that act on it: 3
  • Approved: 2
  • In phases 1 to 3: 1
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 3

Approved2

  • Rasburicase
  • Pegloticase

Phase 31

  • Pegadricase

Phase 20

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Uric acid oxidative enzyme.
      RasburicaseBoxed warningApprovedSanofiProtein or peptideOxidative enzyme3
      PegloticaseBoxed warningApprovedAmgenProtein or peptideOxidative enzyme2
      PegadricasePhase 3Swedish Orphan BiovitrumProtein or peptideOxidative enzyme0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 4 in all, from ClinicalTrials.gov.
      A Study of IN026 in Participants With Refractory GoutRasburicasePhase 1RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyMay 14, 2026
      A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled GoutPegloticasePhase 3RecruitingAmgenFeb 5, 2026
      Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed PatientsPegloticase, RasburicasePhase 2Active, not recruitingArthrosi TherapeuticsAug 12, 2025
      Mature B-Cell Lymphoma And Leukemia Study IIIRasburicasePhase 2 / Phase 3Active, not recruitingSt. Jude Children's Research HospitalJan 12, 2010

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364183, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.